Anpac Bio-Medical Science Pledges $50,000 to UC Davis Child Family Institute for Innovation and Entrepreneurship

Anpac Fellowships Underwrite University of California Students to Attend Scientific Innovation Academies

News provided by

Jan 07, 2016, 07:30 ET

International life sciences leader Anpac Bio-Medical Science Company has developed breakthrough, proprietary, "Cancer Differentiation Analysis" technology that effectively reinvents cancer screening and early detection. Anpac's proprietary CDA medical devices analyze simple, standard, non-invasive "Blood Biopsies" - resulting in measurably greater early cancer detection sensitivity and specificity, with no harmful side effects in patients. The proven results of 25,000 cases to date demonstrate CDA's research validity achieving an average sensitivity and specificity rate range of 75%-90% for ten different types of cancer -- often identifying the type and location of threatening, diseased cancer cells before they form into tumors.

SACRAMENTO, Calif., Jan. 7, 2016 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, has pledged $50,000 to the University of California, Davis Child Family Institute for Innovation and Entrepreneurship (UCDCFIIE) to underwrite student fellowships and support UC Davis' annual Biomedical and Engineering Entrepreneurship Academy.

Anpac's $10,000 per year/five-year commitment will underwrite two UCDCFIIE programs annually: fellowships at the UC Entrepreneurship Academy and sponsorship of UC Davis' annual Biomedical and Engineering Entrepreneurship Academy launch event.

The annual "Anpac Bio-Medical Innovation & Entrepreneur Fellowships" will underwrite five UC students from throughout California to participate in UCDCFIIE's successful UC Entrepreneurship Academy (UCEA). Considered one of UC's premier programs for commercializing science and engineering innovations, the UCEA is a springboard for moving research out of the lab and into the world, providing deep immersion in business planning for aspiring and early-stage scientific innovators.

In addition to the fellowships, Anpac will underwrite UC Davis' Biomedical and Engineering Entrepreneurship Academy (UCDBMEA) opening event.

The UCDBMEA is co-sponsored by the UC Davis Biomedical Engineering Department, School of Medicine, School of Veterinary Medicine, Office of Research and the Child Family Institute for Innovation and Entrepreneurship. The academy's opening event attracts faculty, lab clinicians and postdoctoral students, as well as UC and other academic leaders, corporate and external partners, and elected officials, among others. Anpac Bio-Medical will underwrite and host this event and partner with UC Davis to recruit world-renowned scientists as keynote speakers.

"We are very excited and proud to enter into this new partnership with Anpac Bio-Medical Science Company," states Cleveland Justis, UCDCFIIE executive director. "The Anpac-sponsored fellowships will allow us the funding and flexibility to recruit and award life science's brightest minds, most talented academics, and worthy participants displaying promise as entrepreneurs or 'corporate intrepreneurs,' to attend our academies. Anpac's sponsorship of the Biomedical and Engineering Entrepreneurship Academy will underwrite a terrific launch event and attract world-renowned keynote speakers to inspire our academy students. We are honored that Anpac values our institute's mission and goals. And we look forward to a long and positive relationship with Anpac as we continue to grow our programs and encourage the next generation of scientific innovation."

For more UCDCFIIE information: http://entrepreneurship.ucdavis.edu; for more Anpac Bio-Medical information: www.Anpac.cn.

Logo - http://photos.prnewswire.com/prnh/20151224/318127LOGO

SOURCE Anpac Bio-Medical Science Company